• Naloxone (hydrochloride): Reliable Opioid Antagonist for Lab

  2026-05-09

  This article provides evidence-based guidance for researchers and technicians on optimizing cell viability and opioid receptor signaling assays using Naloxone (hydrochloride) (SKU B8208). Scenario-driven Q&A blocks address real workflow bottlenecks, with a focus on reproducibility, solubility, and validated purity to ensure robust, data-backed results.

• (-)-JQ1: Benchmark Stereoisomer Control for BET Bromodomain

  2026-05-08

  (-)-JQ1, the definitive JQ1 stereoisomer, elevates epigenetics and cancer biology research by providing a gold-standard negative control for BET bromodomain inhibition studies. This guide delivers actionable protocols, troubleshooting insights, and translational context to ensure maximal assay specificity and reproducibility.

• Technical Guide: Using Omeprazole (A2845) in Gastric Acid Re

  2026-05-08

  Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor for controlled gastric acid secretion studies, antiulcer activity, and peptic ulcer disease models. Researchers should avoid diagnostic or clinical applications, as this compound is strictly for laboratory use and workflow optimization.

• BI 2536 (SKU A3965): Precision PLK1 Inhibitor for Reliable C

  2026-05-07

  This article unpacks the laboratory challenges of cell cycle and cytotoxicity assays, demonstrating how BI 2536 (SKU A3965), a potent PLK1 inhibitor, provides reproducible, data-driven solutions. Drawing from peer-reviewed literature and scenario-based insights, it guides researchers in optimizing workflow reliability and experimental accuracy using BI 2536 from APExBIO.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Bioma

  2026-05-07

  Leverage the FITC Goat Anti-Rabbit IgG (H+L) Antibody for high-sensitivity, reproducible detection of rabbit primary antibodies in immunofluorescence and flow cytometry. This reagent empowers translational research, enabling early biomarker discovery and quantitative disease monitoring with robust signal amplification and minimal background.

• DiscoveryProbe™ Metabolism-related Compound Library: Practic

  2026-05-06

  The DiscoveryProbe™ Metabolism-related Compound Library (SKU: L1032) offers a curated solution for researchers needing a robust, QC-validated set of 493 small molecules to interrogate metabolic pathways in vitro and ex vivo. It is best utilized in metabolic enzyme inhibition assays, pathway elucidation, and drug discovery for metabolic diseases or cancer metabolism, but should not be used in diagnostic or clinical settings.

• TNF-alpha Recombinant Murine Protein: A New Era for Translat

  2026-05-06

  This thought-leadership article explores how recent discoveries in non-transcriptional apoptosis, specifically the mechanistic link between RNA Pol II inhibition and cell death, are reshaping the use of TNF-alpha recombinant murine protein in translational research. Integrating cutting-edge evidence, workflow guidance, and competitive analysis, we illuminate the strategic value of APExBIO's TNF-alpha for dissecting immune and apoptotic pathways in advanced disease models.

• Omeprazole (A2845): Practical Guide for H+,K+-ATPase Inhibit

  2026-05-05

  Omeprazole (SKU A2845) is a chemically defined H+,K+-ATPase inhibitor designed for controlled reduction of gastric acid secretion in preclinical research settings. Its use is best suited to in vitro and ex vivo models focusing on gastric acid-related disorders, antiulcer activity studies, and mechanistic workflows involving proton pump inhibition. It is not intended for clinical, diagnostic, or therapeutic use, nor for long-term solution storage applications.

• ARCA EGFP mRNA (5-moUTP): Structure, Stability, and Assay Re

  2026-05-05

  Explore how ARCA EGFP mRNA (5-moUTP) redefines polyadenylated mRNA assay reliability through advanced molecular design, stability insights, and translational efficiency. This article offers a deep, evidence-based perspective beyond conventional transfection optimization.

• Frizzled5 Links Cholesterol Metabolism and Wnt Signaling in

  2026-05-04

  This study defines a direct mechanistic link between aberrant cholesterol metabolism and Wnt/β-catenin signaling in pancreatic ductal adenocarcinoma (PDAC) through the unique cholesterol-binding activity of Frizzled5 (Fzd5). The discovery of cholesterol-driven Fzd5 palmitoylation introduces new molecular targets for therapeutic intervention in Wnt-dependent cancers.

• Clozapine: Mechanisms and Protocols for Schizophrenia Resear

  2026-05-04

  Clozapine is an atypical antipsychotic medication with unique receptor selectivity and robust ERK1/2 signaling activation. It is widely used in schizophrenia research, especially in treatment-resistant models, due to its efficacy and mechanistic depth. This article summarizes quantitative benchmarks, mechanistic rationale, and validated laboratory workflows.

• EZ Cap™ Human PTEN mRNA (ψUTP): Precision Engineering for Tr

  2026-05-03

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP) advances in vitro transcribed mRNA technology for rigorous translational cancer research. This article provides a deeper, evidence-driven analysis of stability enhancement, immune modulation, and protocol optimization.

• Deferasirox: Oral Iron Chelator Empowering Cancer Research

  2026-05-02

  Deferasirox, a clinically validated oral iron chelator, enables precise modulation of iron metabolism and ferroptosis pathways in cancer and hematologic models. This article demystifies experimental workflows, troubleshooting, and advanced use-cases—translating recent mechanistic insights into actionable protocols for researchers.

• Norovirus Exploits NINJ1 for Selective Viral Protein Secreti

  2026-05-01

  Song et al. reveal that murine norovirus (MNoV) co-opts the host protein NINJ1 to enable selective secretion of its NS1 viral protein during infection. This work uncovers a unique mechanism of unconventional protein secretion linked to apoptosis, with implications for understanding viral immune evasion and regulated cell death.

• Anti-Inflammatory, Antiangiogenic Stent Suppresses Airway Re

  2026-05-01

  Zhao et al. introduce a dual-function airway stent (PAGL) combining anti-inflammatory and antiangiogenic actions to address tracheal in-stent restenosis (TISR). Using advanced electrospinning, the study demonstrates robust in vivo and in vitro efficacy against fibroblast activation, angiogenesis, and infection, offering a translationally relevant strategy for stent-associated airway complications.

15476 records 1/1032 page Next 12345 下5页 Last page